PneumoWave develops a respiratory sensor and monitoring platform to assist patients with respiratory conditions in managing their health.
PneumoWave has raised $9.2M in total funding. The most recent round was Series A. The last funding was announced in January 2023.
PneumoWave's investors include Scottish Enterprise, Scottish National Investment Bank, Intuitive Investments Group, Equity Gap, Mark Bamforth.
PneumoWave is headquartered in Holytown, United Kingdom.
PneumoWave develops a respiratory sensor and monitoring platform to assist patients with respiratory conditions in managing their health.
PneumoWave is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PneumoWave — Funding & Investors." VCBacked, January 12, 2023, https://www.vcbacked.co/company/pneumowave. Accessed August 15, 2026.
VCBacked. (2023). PneumoWave — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/pneumowave
{{cite web |title=PneumoWave — Funding & Investors |url=https://www.vcbacked.co/company/pneumowave |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated